Cells - Worksheets, Questions and Revision
18 original exam-style questions - 16 pages of questions with a full mark scheme - free printable PDF.
Cells revision guideMore A Level Sciences practice
This topic is chapter 2 of A Level Biology Topic Workbook and chapter 2 of A Level Biology 10-Minute Tests.
1.2 Cells
- A) Golgi apparatus
- B) Mitochondrion
- C) Ribosome
- D) Lysosome
- A) Plasmid
- B) Cell wall
- C) Membrane-bound nucleus
- D) Ribosomes
Table 1
| Feature | Bacterial cell | Animal cell |
|---|---|---|
| Membrane-bound nucleus | ... | ... |
| Circular DNA (plasmid) | ... | ... |
| 80S ribosomes | ... | ... |
| Mitochondria | ... | ... |
- A) B lymphocyte
- B) T lymphocyte
- C) Phagocyte
- D) Erythrocyte
- A) T helper cell
- B) T killer cell
- C) Plasma cell
- D) Memory cell
- A) Natural active immunity
- B) Artificial active immunity
- C) Natural passive immunity
- D) Artificial passive immunity
- A) They are produced by a single clone of genetically identical plasma cells, so all antibody molecules are identical
- B) They bind to many different antigens at once
- C) They are produced from a mixture of different B cell clones
- D) They are only found in monozygotic twins
W: Chromosomes line up individually along the equator of the cell, attached to spindle fibres.
X: Chromatids are pulled to opposite poles of the cell by the spindle fibres.
Y: Chromosomes condense and become visible; the nuclear envelope breaks down.
Z: Chromatids arrive at the poles and uncoil; nuclear envelopes reform.
Identify which stage of mitosis (prophase, metaphase, anaphase or telophase) matches each description.(4)
Question 1
- (a) B - Mitochondrion caoB1
- (a) Answer: B - Mitochondrion
- (b) C - Membrane-bound nucleus caoB1
- (b) Answer: C - Membrane-bound nucleus
- (c) produces/assembles ribosomes (makes ribosomal RNA, rRNA) (oe)B1
- (c) Answer: It produces ribosomes / makes ribosomal RNA (rRNA) and assembles ribosomes
- (d) the mitochondria carry out aerobic respiration to release ATPB1
- (d) ATP provides the energy needed for the tail (flagellum) to move/beat, propelling the sperm towards the eggB1
- (d) Answer: The mitochondria respire aerobically to produce ATP, which provides the energy needed for the tail (flagellum) to move, allowing the sperm to swim towards the egg
- (e) long hair-like extension of the cell, increasing surface area for absorptionB1
- (e) large number of mitochondria to provide ATP for active transport of mineral ions (or thin cell wall/large permanent vacuole maintaining a steep water potential gradient)B1
- (e) Answer: Any two of: a long root hair/extension of the cell, increasing surface area for absorption; many mitochondria, providing ATP for active transport of mineral ions; thin cell wall/large permanent vacuole to maintain a steep water potential/concentration gradient
Question 2
- (a) membrane-bound nucleus: absent (bacterial); present (animal)B1
- (a) plasmid: present (bacterial); absent (animal)B1
- (a) 80S ribosomes: absent, bacteria have 70S (bacterial); present (animal)B1
- (a) mitochondria: absent (bacterial); present (animal)B1
- (a) Answer: Bacterial: nucleus absent, plasmid present, 80S ribosomes absent (has 70S), mitochondria absent. Animal: nucleus present, plasmid absent, 80S ribosomes present, mitochondria present
- (b) cristae increase the surface area of the inner membrane (oe)B1
- (b) providing more space for electron transport chain proteins / ATP synthase enzymesB1
- (b) increasing the rate of ATP production by aerobic respirationB1
- (b) Answer: Cristae increase the surface area of the inner mitochondrial membrane, providing more space for electron transport chain proteins and ATP synthase, increasing the rate of ATP production by aerobic respiration
- (c) protein synthesised by ribosomes on the rough endoplasmic reticulum (RER)B1
- (c) protein enters the RER and is folded/processed, then a vesicle buds off carrying the proteinB1
- (c) vesicle fuses with the Golgi apparatus, where the protein is modified and packagedB1
- (c) a secretory vesicle buds off the Golgi, moves to and fuses with the cell-surface membrane, releasing the protein by exocytosisB1
- (c) Answer: Ribosomes on the RER synthesise the protein; it enters the RER and is packaged into a vesicle; the vesicle fuses with the Golgi apparatus where the protein is modified and packaged; a secretory vesicle buds off the Golgi and fuses with the cell-surface membrane, releasing the protein by exocytosis
Question 3
- (a) BB1
- (a) Answer: B
- (b) CB1
- (b) Answer: C
- (c) DB1
- (c) Answer: D
- (d) AB1
- (d) Answer: A
Question 4
- (a) converts 0.40 mm to 400 micrometres (or equivalent correct method)M1
- (a) 20 micrometres caoA1
- (a) Answer: 20 micrometres
- (b) 15 x 20 (or correct method using their value from (a), ft)M1
- (b) 300 micrometres cao (ft from (a))A1
- (b) Answer: 300 micrometres
- (c) converts 45 mm to 45000 micrometresM1
- (c) magnification = image size / actual size = 45000 / 300 (dependent on M1)dM1
- (c) x150 caoA1
- (c) Answer: x150
- (d) magnification is the ratio of image size to actual (real) object size, i.e. how much bigger the image is (oe)B1
- (d) resolution is the minimum distance between two points at which they can still be distinguished as separate (oe)B1
- (d) Answer: Magnification = how much bigger the image is than the real object (ratio of image size to actual size); Resolution = the minimum distance between two points at which they can still be seen as separate objects
Question 5
- (a) the minimum distance between two points/objects at which they can still be distinguished as separate (oe)B1
- (a) Answer: The minimum distance between two points that can still be seen/distinguished as two separate points
- (b) electrons have a much shorter wavelength than lightB1
- (b) a shorter wavelength gives a higher resolution (allows smaller/closer structures to be distinguished)B1
- (b) Answer: Electrons have a much shorter wavelength than light, and a shorter wavelength gives a higher resolution
- (c) converts 500 mm to 500000 micrometresM1
- (c) magnification = image size / actual size = 500000 / 4.2 (dependent on M1)dM1
- (c) x120000 (1.2 x 105) awrt 2 s.f.A1
- (c) Answer: x120000 (1.2 x 105) to 2 s.f.
- (d) specimens must be dead, dehydrated, chemically fixed and stained, and viewed in a vacuum, so cannot be living (oe)B1
- (d) only a thin 2D section is seen, so the whole 3D living structure / dynamic processes cannot be observed (oe, any second valid point)B1
- (d) Answer: TEM specimens must be dead, dehydrated and stained (viewed in a vacuum), so living processes cannot be observed; only a thin 2D section is seen, not the whole 3D living structure
Question 6
- (a) interphase: cell grows and DNA/organelles are replicated (cell prepares for division)B1
- (a) mitosis: the nucleus divides, producing two genetically identical nucleiB1
- (a) cytokinesis: the cytoplasm (and cell membrane) divides, producing two separate daughter cellsB1
- (a) Answer: Interphase: cell growth and DNA replication/organelle duplication; Mitosis: nuclear division producing two genetically identical nuclei; Cytokinesis: division of the cytoplasm to form two separate daughter cells
- (b) W = metaphaseB1
- (b) X = anaphaseB1
- (b) Y = prophaseB1
- (b) Z = telophaseB1
- (b) Answer: W = metaphase; X = anaphase; Y = prophase; Z = telophase
- (c) 18 / 240M1
- (c) 0.075 (or 7.5%) caoA1
- (c) Answer: 0.075 (7.5%)
- (d) a higher mitotic index means a greater proportion of cells are dividing at any one timeB1
- (d) this suggests mitosis/the cell cycle is no longer controlled properly (uncontrolled cell division), characteristic of a tumourB1
- (d) Answer: A high mitotic index shows that a large proportion of cells are dividing at any given time, indicating uncontrolled cell division (loss of control of the cell cycle), which is characteristic of a tumour
Question 7
- (a) net movement of molecules/particles from a region of higher concentration to a region of lower concentration (down a concentration gradient), due to random motion; requires no metabolic energy (oe)B1
- (a) Answer: Net movement of molecules/particles from a region of higher concentration to a region of lower concentration (down a concentration gradient), as a result of their random motion; requires no input of metabolic energy
- (b) surface area available for diffusion (larger SA = faster rate)B1
- (b) concentration gradient/difference in concentration (steeper gradient = faster rate)B1
- (b) thickness of membrane/diffusion distance, or temperature (thinner/warmer = faster rate)B1
- (b) Answer: Any three of: surface area available for diffusion; the concentration gradient (difference in concentration); the thickness of the membrane/diffusion distance; temperature
- (c) surface area = 6 x 32 = 54 mm2M1
- (c) volume = 33 = 27 mm3M1
- (c) ratio = 54 / 27 (dependent on both previous marks)dM1
- (c) 2 : 1 (or 2.0) caoA1
- (c) Answer: SA = 54 mm2; V = 27 mm3; SA:V ratio = 2 : 1
- (d) surface area = 6 x 92 = 486 mm2 and volume = 93 = 729 mm3M1
- (d) ratio = 0.67 : 1 awrt (486/729 = 0.667) caoA1
- (d) as size/volume increases, the SA:V ratio decreases, so the diffusion distance/pathway to the centre increasesB1
- (d) surface area is too small relative to volume to supply oxygen/nutrients or remove waste/heat fast enough by diffusion alone, so specialised exchange surfaces are neededB1
- (d) Answer: SA:V ratio = 0.67:1 (486 mm2 : 729 mm3). Larger organisms have a smaller SA:V ratio, so diffusion alone across the outer body surface cannot supply oxygen/nutrients or remove wastes fast enough, so specialised exchange surfaces (with adaptations to increase SA and reduce diffusion distance) are needed
Question 8
- (a) phospholipids are amphipathic: the phosphate head is hydrophilic and the fatty acid tails are hydrophobic oeB1
- (a) in water, the hydrophilic heads orientate towards the water on both sides while the hydrophobic tails face inwards, away from water, forming a bilayer oeB1
- (a) Answer: Because phospholipids have a hydrophilic head and hydrophobic tails, they arrange with heads facing the water on both sides and tails facing each other, forming a bilayer.
- (b) cholesterol molecules fit between the phospholipids, binding to their fatty acid tails oeB1
- (b) at high temperatures cholesterol restricts the movement of phospholipids, reducing fluidity and preventing the membrane becoming too fluid/permeable oeB1
- (b) at low temperatures cholesterol prevents phospholipids from packing too closely together, maintaining fluidity and preventing the membrane becoming too rigid oeB1
- (b) Answer: Cholesterol sits between phospholipid tails; at high temperatures it restricts movement to stop the membrane becoming too fluid, and at low temperatures it prevents tight packing, stopping the membrane becoming too rigid, so fluidity is maintained across a range of temperatures.
- (c) intrinsic (integral) proteins span or are embedded within the phospholipid bilayer oeB1
- (c) extrinsic (peripheral) proteins are attached to the surface of the bilayer (do not span it) oeB1
- (c) Answer: Intrinsic proteins are embedded within (or span) the bilayer; extrinsic proteins sit on its surface without spanning it.
- (d) the carbohydrate (glycolipid/glycoprotein) chains act as antigens/cell-surface receptors that allow the immune system (or other cells) to recognise the cell as self or identify it as a specific cell type oeB1
- (d) Answer: Glycoproteins act as antigens or recognition sites, allowing cells (including immune cells) to identify the cell as self or as a particular cell type.
Question 9
- (a) cells in mitosis = 14 + 8 + 6 + 4 = 32M1
- (a) mitotic index = 32 / 200M1
- (a) 0.160, caoA1
- (a) Answer: 0.160
- (b) interphase is the longest part of the cell cycle, during which the cell grows and replicates its DNA, so at any moment most cells are in interphase oeB1
- (b) each stage of mitosis is comparatively brief, so fewer cells are 'caught' in that stage at any one time oeB1
- (b) Answer: Interphase takes up most of the cell cycle (growth and DNA replication occur here), while each mitotic stage is brief, so far fewer cells are seen in mitosis at any snapshot in time.
- (c) a higher mitotic index suggests a much greater proportion of cells are undergoing mitosis at any time, i.e. the cells are dividing more frequently/rapidly oeB1
- (c) this suggests loss of normal control over the cell cycle (e.g. checkpoint failure, uncontrolled proliferation), characteristic of cancerous/tumour cells oeB1
- (c) uncontrolled cell division can lead to tumour growth, so a high mitotic index is used clinically as an indicator of tumour grade/how aggressively it may grow oeB1
- (c) Answer: A mitotic index of 0.420 suggests cells are dividing much more frequently, indicating a loss of normal cell cycle control typical of tumour cells; clinically this is used as a marker of how aggressively a tumour may grow.
Question 10
- (a) sodium ions are actively transported (using ATP) out of the epithelial cell across the basal membrane into the blood, by the sodium-potassium pumpB1
- (a) this maintains a low concentration of sodium ions inside the epithelial cell, creating a concentration gradient for sodium ions between the lumen and the cytoplasmB1
- (a) sodium ions diffuse from the lumen into the epithelial cell down this concentration gradient, through a co-transporter protein in the cell-surface (apical) membraneB1
- (a) glucose is carried into the cell at the same time (against its own concentration gradient) via the co-transporter protein, then diffuses into the blood by facilitated diffusionB1
- (a) Answer: Sodium ions are actively pumped out of the epithelial cell into the blood by the sodium-potassium pump, maintaining a low Na+ concentration inside the cell; Na+ then diffuses from the lumen into the cell down its concentration gradient via a co-transporter protein, carrying glucose in with it (against its own gradient); glucose then diffuses into the blood via facilitated diffusion
- (b) active transport (of sodium ions by the sodium-potassium pump) requires ATPB1
- (b) mitochondria carry out aerobic respiration to produce this ATP, so many are needed to supply enough energy for active transportB1
- (b) Answer: Active transport of sodium ions by the sodium-potassium pump requires ATP; mitochondria produce ATP by aerobic respiration, so many are needed to supply enough energy for this active transport
- (c) active transport requires ATP (uses metabolic energy), whereas facilitated diffusion does not (it is passive)B1
- (c) active transport can move substances against (up) a concentration gradient, whereas facilitated diffusion only moves substances down a concentration gradientB1
- (c) Answer: Active transport requires ATP and can move substances against a concentration gradient; facilitated diffusion needs no ATP and only moves substances down a concentration gradient.
Question 11
- (a) tissue is homogenised (e.g. in a blender) in a cold, buffered, isotonic solution to break open cells and release organellesB1
- (a) the homogenate is filtered to remove debris/whole cells/connective tissueB1
- (a) Answer: The tissue is homogenised (blended) in a cold, buffered, isotonic solution to break open the cells and release the organelles; the homogenate is then filtered to remove any large debris or unbroken cells/tissue
- (b) ice-cold: reduces enzyme activity/respiration, preventing autolysis/digestion of organellesB1
- (b) isotonic: prevents organelles gaining or losing water by osmosis and bursting or shrinkingB1
- (b) buffered: keeps pH constant, preventing denaturation of proteins/enzymesB1
- (b) Answer: Ice-cold: reduces enzyme activity, preventing autolysis of organelles; Isotonic: prevents organelles gaining or losing water by osmosis and bursting or shrinking; Buffered: keeps pH constant, preventing denaturation of proteins/enzymes
- (c) nuclei first, at the lowest speed (densest/largest organelle)B1
- (c) then mitochondria, then ribosomes last, at the highest speed (both needed for the mark, correct order)B1
- (c) Answer: Nuclei first (lowest speed), then mitochondria, then ribosomes last (highest speed) - i.e. order of decreasing density/size
- (d) view the fraction using an electron microscope (high enough resolution to see organelle detail)B1
- (d) check that only structures with the features of mitochondria (e.g. double membrane, cristae) are present, with no other organelle types visibleB1
- (d) Answer: View the fraction under an electron microscope and check that only structures with the features of mitochondria (double membrane, cristae) are present, with no other organelle types visible
Question 12
- (a) totipotent: can differentiate into any cell type, including extra-embryonic/placental tissue (found only in the early embryo)B1
- (a) pluripotent: can differentiate into almost any cell type but not extra-embryonic tissue (e.g. embryonic stem cells)B1
- (a) multipotent: can differentiate into a limited/restricted range of related cell types (e.g. adult bone marrow stem cells)B1
- (a) Answer: Totipotent: can become any cell type including extra-embryonic tissue; Pluripotent: can become almost any cell type (not extra-embryonic tissue); Multipotent: can become a limited range of related cell types
- (b) L3 Detailed and accurate discussion of both medical uses and ethical issues, with a balanced argument and clear scientific reasoning linking stem cell type to therapeutic potential. Uses a range of relevant, correctly applied biological terminology throughout.5-6
- (b) L2 Reasonable discussion of medical uses and/or ethical issues, with some scientific reasoning, though the argument may be one-sided or contain minor inaccuracies or omissions. Mostly correct use of terminology.3-4
- (b) L1 Basic or generalised statements about stem cells, medical uses or ethical issues with little linking or scientific detail. Limited use of appropriate terminology.1-2
- (b) L0 No relevant content.0
- (b) Indicative content:
- Embryonic stem cells are pluripotent and can be used to grow replacement cells/tissues for a wide range of diseases (e.g. Parkinson's disease, spinal cord injury, diabetes, heart disease)
- Adult (multipotent) stem cells, e.g. from bone marrow, are already used to treat blood disorders/leukaemia (bone marrow transplants) but can only form a limited range of cell types
- Embryonic stem cells are usually obtained from spare embryos created during IVF, which are then destroyed; some people believe this is morally wrong because they consider the embryo to have the same moral status/right to life as a person
- Others argue the potential benefit to patients suffering serious disease or injury outweighs the moral status of a very early embryo, especially as the embryos would otherwise be discarded
- Using adult stem cells avoids this ethical issue but adult stem cells are harder to obtain, less versatile (only multipotent) and may have accumulated mutations with age
- Induced pluripotent stem (iPS) cells can be created by reprogramming adult body cells, avoiding the need to destroy embryos, but there are concerns about safety (e.g. risk of uncontrolled cell division/tumour formation)
- Consent issues: patients/couples must give informed consent for embryos to be used in research
- (b) Answer: Level 3 response balancing therapeutic potential (embryonic vs adult vs iPS cells) against the ethical concerns of embryo destruction, consent and safety
Question 13
- (a) phospholipid bilayer forms the basic structure, hydrophilic heads facing out (towards water) and hydrophobic tails facing inwardsB1
- (a) phospholipids/proteins can move (laterally) within the layer, giving a fluid structureB1
- (a) proteins form a mosaic pattern; integral proteins are embedded in the bilayer and may span it or occupy one leaflet, while peripheral proteins associate with the membrane surfaceB1
- (a) cholesterol is present between phospholipids, adding stability and regulating fluidity (accept glycoproteins/glycolipids for cell signalling/recognition)B1
- (a) Answer: A bilayer of phospholipids (hydrophilic heads out, hydrophobic tails in) that can move, giving a fluid structure; proteins form a mosaic pattern, with integral proteins embedded in the bilayer (spanning it or occupying one leaflet) and peripheral proteins associated with its surface; cholesterol sits between phospholipids adding stability
- (b) at higher temperatures, phospholipids/proteins gain more kinetic energy and move more, making the bilayer more fluid (oe)B1
- (b) above about 40°C, membrane (channel/carrier) proteins begin to denature and the phospholipid bilayer structure begins to break downB1
- (b) this makes the membrane much more permeable, so more pigment (betalain) leaks out, increasing absorbance sharplyB1
- (b) Answer: Above about 40°C, increased kinetic energy causes phospholipids to move more and membrane proteins to denature, breaking down the membrane structure; this makes the membrane much more permeable, so more pigment leaks out and absorbance increases sharply
- (c) size (surface area/volume) of the beetroot cylindersB1
- (c) any second valid control variable, e.g. time in the water bath, volume of water surrounding each cylinder, source/species of beetrootB1
- (c) Answer: Any two of: size (surface area/volume) of the beetroot cylinders; time left in the water bath; volume of water surrounding each cylinder; species/source of beetroot used
- (d) 0.66 awrt (0.657 to 3 s.f.) caoA1
- (d) Answer: 0.66 (0.657 to 3 s.f.)
Question 14
- (a) recognise that rate is directly proportional to surface area when concentration difference and thickness are unchangedM1
- (a) scale factor = 900 / 400 = 2.25, so new rate = 24 x 2.25M1
- (a) 54 arbitrary units, caoA1
- (a) Answer: 54 arbitrary units
- (b) as an object increases in size, volume increases faster than surface area (volume increases with the cube of linear dimension, surface area with the square), so the surface area to volume ratio falls oeB1
- (b) diffusion rate depends on surface area available for exchange, while metabolic demand depends on volume oeB1
- (b) in a large cell, the smaller surface area to volume ratio means diffusion alone cannot supply substances (e.g. oxygen, nutrients) or remove wastes fast enough to meet the demands of the whole volume, limiting maximum cell size oeB1
- (b) Answer: Volume increases faster than surface area as size increases, so larger cells have a lower surface area to volume ratio; because diffusion depends on surface area but demand depends on volume, this limits how large a cell can be while still being adequately supplied by diffusion alone.
- (c) rate is inversely proportional to thickness, so new rate / old rate = 8.0 / 12.0 = 0.667M1
- (c) a decrease of 33.3% (cao); accept new rate is 66.7% of the originalA1
- (c) Answer: The rate decreases by approximately 33.3%.
Question 15
- (a) a mouse (or other animal) is exposed to the target antigen (hCG), stimulating specific B lymphocytes to produce the complementary antibody oeB1
- (a) these B lymphocytes are fused with a tumour cell (myeloma) to form a hybridoma, which can divide indefinitely (immortal) while still producing the specific antibody oeB1
- (a) hybridoma cells are cloned, and the clone producing the antibody with the highest specificity to hCG is selected and cultured to produce large quantities of identical (monoclonal) antibody oeB1
- (a) Answer: B lymphocytes producing anti-hCG antibody are fused with myeloma cells to form immortal hybridomas, which are cloned and screened to select a clone producing the required antibody in bulk.
- (b) the antibody's variable region/binding site has a shape (tertiary structure) complementary only to hCG oeB1
- (b) a different hormone would have a different molecular shape and so would not bind (or bind poorly) to the antibody, giving no colour change/no positive result oeB1
- (b) Answer: The antibody's binding site is complementary in shape only to hCG; a different hormone would not fit and so would not trigger a positive (colour) result.
- (c) a valid benefit, e.g. rapid, specific, low-cost diagnosis; targeted cancer therapy reduces damage to healthy cells compared with non-specific chemotherapy oeB1
- (c) a valid drawback, e.g. animal use in production raises ethical concerns; production and therapy can be expensive/limit access; possible immune reactions to the antibody oeB1
- (c) Answer: Benefits include rapid, specific and relatively cheap diagnosis, and more targeted, less damaging cancer treatment; drawbacks include the ethical concerns of using animals in production, high cost limiting access, and possible immune reactions to the antibody.
Question 16
- (a) RNAB1
- (a) reverse transcriptaseB1
- (a) Answer: RNA; the enzyme reverse transcriptase converts it into DNA.
- (b) a glycoprotein on the surface of HIV binds specifically (is complementary) to the CD4 receptor protein on the surface of the T helper cell oeB1
- (b) the viral envelope fuses with the cell-surface membrane, releasing the viral RNA/contents into the T helper cell oeB1
- (b) Answer: A viral glycoprotein binds specifically to the CD4 receptor on the T helper cell; the viral envelope then fuses with the cell membrane, releasing its contents into the cell.
- (c) T helper cells release cytokines/interleukins that stimulate B cells to divide and differentiate into plasma cells, and stimulate T killer cells to become active oeB1
- (c) with fewer T helper cells, this stimulation is reduced, so fewer plasma cells (and therefore less antibody) and fewer active T killer cells are produced oeB1
- (c) this weakens both the humoral and cell-mediated immune responses, so the body cannot mount an effective response to pathogens that it would normally destroy oeB1
- (c) Answer: Because T helper cells stimulate both B cells (antibody production) and T killer cells, fewer T helper cells means a weaker humoral and cell-mediated response, leaving the body unable to fight off infections it would normally clear.
- (d) the enzyme, linked to a secondary antibody that binds the patient's HIV antibody, catalyses a reaction with a colourless substrate to produce a coloured product; the intensity of colour is proportional to the amount of antibody present, and can be measured with a colorimeter oeB1
- (d) Answer: The linked enzyme converts a colourless substrate into a coloured product; the depth of colour, measurable with a colorimeter, is proportional to the amount of HIV antibody present in the sample.
Question 17
- Level 3 A detailed, well-structured evaluation explaining how vaccination stimulates active immunity and immunological memory, how a sufficiently high proportion of vaccinated individuals reduces transmission and protects unvaccinated people (herd immunity), and discusses at least two factors that limit the effectiveness of a vaccination programme (e.g. antigenic variability, uptake rate, individual variation in response), with a supported overall judgement.5-6
- Level 2 A reasonably clear account of how vaccination produces immunity and contributes to herd immunity, with at least one relevant limiting factor discussed, but the evaluation is not fully balanced or a key idea (e.g. memory cells, threshold proportion) is only partially explained.3-4
- Level 1 Basic description of vaccination producing immunity, with little or no explanation of herd immunity or limiting factors; limited use of biological terminology.1-2
- Indicative content:
- Vaccination introduces antigenic material (attenuated pathogen, dead pathogen, or isolated antigen) which triggers a primary immune response, producing antibodies and, crucially, memory B and T cells.
- If the vaccinated individual later meets the live pathogen, memory cells allow a rapid secondary immune response, destroying the pathogen before symptoms/harm occur - this is active, artificial immunity.
- If a sufficiently high proportion of the population is vaccinated, the pathogen cannot easily spread from person to person, breaking chains of transmission.
- This protects individuals who cannot be vaccinated (e.g. immunocompromised people, newborns, allergy to a vaccine component) because they are unlikely to come into contact with an infected person - this is herd immunity.
- Limiting factors: some pathogens (e.g. influenza) show antigenic variation, so vaccines must be updated regularly and past immunity may not protect against new strains.
- Limiting factors: uptake below the threshold needed for herd immunity leaves gaps allowing outbreaks; individual variation in immune response means some vaccinated people may not develop full immunity; cost, access and vaccine hesitancy affect uptake.
- A balanced evaluation weighs strong reduction in disease incidence and protection of vulnerable groups against these practical and biological limitations, reaching a supported conclusion.
Question 18
- (a) totipotent cells can differentiate into any cell type, including extra-embryonic tissue (e.g. placenta); found in the very early embryo (e.g. the zygote/cells up to the 8-cell stage) oeB1
- (a) pluripotent cells can differentiate into almost any body cell type but not extra-embryonic tissue; found in the embryonic inner cell mass (blastocyst) oeB1
- (a) correct named source given for each (e.g. zygote/early embryo for totipotent; inner cell mass of the blastocyst for pluripotent)B1
- (a) Answer: Totipotent cells (e.g. the zygote) can form any cell type including extra-embryonic tissue; pluripotent cells (e.g. the inner cell mass of the blastocyst) can form almost any body cell type but not extra-embryonic tissue.
- (b) the introduced transcription factors switch on (or switch off) specific genes that were previously inactive (or active) in the differentiated cell oeB1
- (b) this alters the pattern of gene expression back to that of an undifferentiated/embryonic-like cell, restoring the potential to differentiate into a wide range of cell types oeB1
- (b) Answer: The transcription factors alter which genes are expressed, resetting the cell's pattern of gene expression to an embryonic-like state, restoring its potential to differentiate into many cell types.
- (c) a valid advantage, e.g. avoids the ethical concerns of destroying embryos to obtain stem cells oeB1
- (c) a valid supporting point, e.g. iPS cells can be made from the patient's own cells, reducing the risk of immune rejection if used therapeutically oeB1
- (c) Answer: iPS cells avoid the ethical issues of destroying embryos, and can be derived from a patient's own cells, reducing the risk of immune rejection if used in therapy.
Mark your answers
Check answers without an account. Some answers can be checked automatically; use the mark scheme to mark the rest.